Developed following the 2020 release of its Covid Travel Safe product, its latest, more comprehensive tool offers automated assessments of the medical, logistical and security risks posed to staff who travel on behalf of the company for work.

Healix Travel Safe provides an assessment based on analysis of the employee’s unique profile, relevant medical history and proposed itinerary to identify those who may be at increased risk of encountering various dangers and their likely impact. A dedicated portal also enables employers to access a report detailing assessment outcomes for all employees using a traffic light system.

Healix anticipates work-related travel to recover to pre-pandemic levels by the end of 2024.

"Travelling for work can be an apprehensive venture in the context of the current climate of geopolitical volatility, recent natural disasters and other risk factors," said Charlie Butcher, CEO at Healix International. "By aligning with the latest ISO standard businesses can ensure the safety of their people, but to do so re-quires a thorough assessment of both the health of the traveller and their end destination. It is only with a clear understanding of which employees are more vulnerable and what threats certain locations can pose that a clear plan can be built to ensure the safety of their workforce.

“After the success of the Covid Travel Safe tool in addressing Covid-related risks, we have built out the original product to create Healix Travel Safe. This will provide employers the ability to plan and mitigate risk, in line with the global standard, but also gives travelling employees peace of mind and the knowledge that their employer is doing all they can to protect the safety of their workforce.”

Share Story: